Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2004 2
2005 2
2006 2
2007 1
2008 3
2009 1
2010 2
2011 3
2012 4
2013 6
2014 9
2015 13
2016 6
2017 5
2018 7
2019 8
2020 15
2021 5
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
[Apoptosis modulation by human papillomavirus].
Jave-Suárez LF, Ratkovich-González S, Olimón-Andalón V, Aguilar-Lemarroy A. Jave-Suárez LF, et al. Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 2:S200-5. Rev Med Inst Mex Seguro Soc. 2015. PMID: 26462517 Review. Spanish.
[Wnt signalling pathway and cervical cancer].
Ramos-Solano M, Álvarez-Zavala M, García-Castro B, Jave-Suárez LF, Aguilar-Lemarroy A. Ramos-Solano M, et al. Among authors: jave suarez lf. Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 2:S218-24. Rev Med Inst Mex Seguro Soc. 2015. PMID: 26462520 Review. Spanish.
[History of breast cancer].
Barrón-Gallardo CA, Jave-Suarez LF, Aguilar-Lemarroy A. Barrón-Gallardo CA, et al. Among authors: jave suarez lf. Rev Med Inst Mex Seguro Soc. 2020 Apr 27;58(Supl 1):S75-S82. doi: 10.24875/RMIMSS.M20000117. Rev Med Inst Mex Seguro Soc. 2020. PMID: 34695318 Spanish.
Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and SERPINE1 Expression in CaSki Cells.
Palafox-Mariscal LA, Ortiz-Lazareno PC, Jave-Suárez LF, Aguilar-Lemarroy A, Villaseñor-García MM, Cruz-Lozano JR, González-Martínez KL, Méndez-Clemente AS, Bravo-Cuellar A, Hernández-Flores G. Palafox-Mariscal LA, et al. Among authors: jave suarez lf. Int J Mol Sci. 2023 Jun 24;24(13):10592. doi: 10.3390/ijms241310592. Int J Mol Sci. 2023. PMID: 37445768 Free PMC article.
Breast cancer chemotherapy treatment monitoring based on serum sample Raman spectroscopy.
Torre-Gutiérrez LG, Martínez-Zérega BE, Oseguera-Galindo DO, Aguilar-Lemarroy A, Jave-Suárez LF, Torres-González LA, González-Solís JL. Torre-Gutiérrez LG, et al. Among authors: jave suarez lf. Lasers Med Sci. 2022 Dec;37(9):3649-3659. doi: 10.1007/s10103-022-03646-5. Epub 2022 Oct 14. Lasers Med Sci. 2022. PMID: 36239879 Free PMC article.
E6/E7 from Beta-2-HPVs 122, 38b, and 107 possess transforming properties in a fibroblast model in vitro.
Castro-Amaya AM, Fernández-Avila L, Barrón-Gallardo CA, Moreno-Rios CE, Guevara-Hernández SN, Magaña-Torres MT, Pelayo-Aguirre CJ, Jave-Suárez LF, Aguilar-Lemarroy A. Castro-Amaya AM, et al. Among authors: jave suarez lf. Exp Cell Res. 2022 May 15;414(2):113088. doi: 10.1016/j.yexcr.2022.113088. Epub 2022 Mar 8. Exp Cell Res. 2022. PMID: 35276208 Free article.
Identification and characterization of the V3 promoter of the ST3GAL4 gene.
Martínez-Morales PL, Ortiz-Mateos CA, Reyes-Pineda J, Reyes-Vallejo T, Aguilar-Lemarroy A, Jave-Suárez LF, Santos-López G, Reyes-Leyva J, Milflores-Flores L, Vallejo-Ruiz V. Martínez-Morales PL, et al. Among authors: jave suarez lf. Biosci Trends. 2020 May 21;14(2):144-150. doi: 10.5582/bst.2019.01331. Epub 2020 Apr 15. Biosci Trends. 2020. PMID: 32295993 Free article.
Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers.
Barrón-Gallardo CA, Garcia-Chagollán M, Morán-Mendoza AJ, Delgadillo-Cristerna R, Martínez-Silva MG, Aguilar-Lemarroy A, Jave-Suárez LF. Barrón-Gallardo CA, et al. Among authors: jave suarez lf. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211068965. doi: 10.1177/15330338211068965. Technol Cancer Res Treat. 2022. PMID: 34981997 Free PMC article.
101 results